He was then transferred to the [**Hospital1 69**] for further evaluation of his obstructive jaundice and possible surgical intervention.
Endoscopic retrograde cholangiopancreatography ([**2170-8-31**]) revealed (1) ampullary mass; (2) biliary dilatation compatible with distal obstruction; (3) stent placement in the common bile duct; (4) gastric mucosal changes consistent with portal hypertensive gastropathy.
In light of the patient's liver disease, the patient was deemed not to be suitable for a Whipple; and, therefore, a Roux-en-Y choledochal jejunostomy was performed.
He was started on Aldactone 100 mg by mouth daily for management of his fluid status.
He was to continue this medication as an outpatient.
On postoperative day eight, fluid from the [**Location (un) 1661**]-[**Location (un) 1662**] drain was sent for cell count, cytology, and cultures.
He was started on intravenous Unasyn for treatment of spontaneous bacterial peritonitis.
The patient was then started on vancomycin intravenously which was subsequently dosed by levels.
He underwent a diagnostic paracentesis on [**2170-9-20**] for further evaluation of his ascites fluid.
He was continued on intravenous antibiotics until the day of discharge.
However, following the patient's CT scan with intravenous contrast, the patient developed an increase in his creatinine to 2.4.
The [**Initials (NamePattern4) 228**] [**Last Name (NamePattern4) 1661**]-[**Location (un) 1662**] drain was removed on postoperative day eight.
A stitch was placed at the [**Location (un) 1661**]-[**Location (un) 1662**] drain site, and there was no evidence of leakage for the next one to two days.
On the day of discharge, an additional two stitches were placed at the [**Location (un) 1661**]-[**Location (un) 1662**] drain site; however, there were still amounts of fluid coming out from the site.
Status post cholecystectomy, Roux-en-Y hepaticojejunostomy, liver biopsy, and pancreatic biopsy.
Augmentin 875 mg p.o.
Ciprofloxacin 500 mg p.o.
Aldactone 100 mg p.o.
Protonix 40 mg p.o.
